Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of everolimus in pediatric SEGA
NCT02338609Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2014
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of everolimus in subependymal giant cell astrocytoma (SEGA), sponsored by Novartis. Started Dec 2014; status: completed.
02
Drugs
everolimus
03
Conditions
subependymal giant cell astrocytoma (SEGA)
Beyond the preview
Go deeper on NCT02338609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338609.